InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Hallock Kenneth, Director. Director active across 1 companies, notably Greenwich LifeSciences, Inc.. In total, 2 reports have been recorded. Total volume traded: €9k. The latest transaction was filed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€4,327300 shares@ €14.42490.0011% mcap100.0% of flow
Common Stock
SEC:0001493152-22-002020·
Ideal exit: 18 Oct 2022 (T+270)
€4,327300 shares@ €14.42490.0011% mcap50.0% of flow
Common Stock
SEC:0001493152-22-002020:0·
Ideal exit: 18 Oct 2022 (T+270)
2 of 2 declarations
About Hallock Kenneth
Kenneth Hallock is a Director at Greenwich LifeSciences, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. With expertise in the life sciences field, he brings valuable insights to the board, contributing to the company's strategic direction.
